Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
27
Recruiting, any sponsor type, condition "overactive bladder"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed341
27 trials
Showing 1 to 25, recently updated first.
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson DiseasePivotal-lookingRecruiting
VA Office of Research and DevelopmentFederal agency
NCT07187466 · 146 participants (planned) · Start Nov 9, 2026 · Primary completion Mar 31, 2030
Drug: mirabegron · For: Overactive Bladder; Parkinson Disease
Sites: Decatur, Georgia; Philadelphia, Pennsylvania; Salt Lake City, Utah
- Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive BladderRecruiting
Bagcilar Training and Research HospitalGovernment (non-federal)
NCT07773532 · 115 participants (planned) · Start Nov 2, 2026 · Primary completion Nov 2, 2027
Drug: Mirabegron (beta3-adrenoceptor agonist) · For: Overactive Bladder (OAB)
Sites: Istanbul, Turkey (Türkiye)
- Antibiotic Prophylaxis for Bladder BotoxPivotal-lookingRecruiting
University of AlbertaAcademic, hospital or other
NCT04444440 · 202 participants (planned) · Start Jun 28, 2021 · Primary completion Jun 30, 2028
Drug: Ciprofloxacin · For: Idiopathic Overactive Bladder; Postoperative Urinary Tract Infection
Sites: Edmonton, Canada
- Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA InjectionPivotal-lookingRecruiting
Women and Infants Hospital of Rhode IslandAcademic, hospital or other
NCT06953271 · 164 participants (planned) · Start Aug 1, 2025 · Primary completion Jan 30, 2027
Drug: Methenamine Hippurate; Typically prescribed oral antibiotic prophylaxis · For: Overactive Bladder (OAB); Urinary Tract Infection (Diagnosis)
Sites: Providence, Rhode Island
- Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsPivotal-lookingRecruiting
The Cleveland ClinicAcademic, hospital or other
NCT07648290 · 260 participants (planned) · Start Jul 31, 2026 · Primary completion Mar 31, 2028
Drug: Macrobid® Capsules 100 mg · For: Overactive Bladder
Sites: Cleveland, Ohio
- Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)Pivotal-lookingRecruiting
FemPulse CorporationIndustry
NCT07195656 · 151 participants (planned) · Start Sep 30, 2025 · Primary completion May 31, 2027
Drug: Medication Group · For: Overactive Bladder (OAB)
Sites: Beverly Hills, California; Los Angeles, California; Orange, California · 15 sites in all
Endeavor HealthAcademic, hospital or other
NCT07405554 · 72 participants (planned) · Start Feb 26, 2026 · Primary completion Dec 2026
Drug: Zinc Citrate Oral Capsule; Placebo · For: Overactive Bladder (OAB)
Sites: Skokie, Illinois
- Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)Pivotal-lookingRecruiting
University of AarhusAcademic, hospital or other
NCT06551246 · 236 participants (planned) · Start Jun 27, 2024 · Primary completion Oct 1, 2027
Drug: Solifenacin; Mirabegron · For: Urinary Incontinence in Children
Sites: Aalborg, Denmark; Aarhus, Denmark; Esbjerg, Denmark · 5 sites in all
- Antibiotic Prophylaxis for Neurogenic Bladder BotoxPivotal-lookingRecruiting
University of AlbertaAcademic, hospital or other
NCT04791579 · 160 participants (planned) · Start Feb 1, 2025 · Primary completion Mar 31, 2027
Drug: Ciprofloxacin; Placebo · For: Neurogenic Bladder; Post-operative Urinary Tract Infections
Sites: Edmonton, Canada
- Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-WetPivotal-lookingRecruiting
Children's Hospital of Chongqing Medical UniversityAcademic, hospital or other
NCT06201013 · 180 participants (planned) · Start Apr 20, 2026 · Primary completion Sep 15, 2026
Drug: Solifenacin Succinate; Vitamin D3 · For: Urinary Bladder, Overactive; Overactive Bladder; Urinary Incontinence, Urge
Sites: Chongqing, China
- Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder DysfunctionPivotal-lookingRecruiting
Central Hospital, Nancy, FranceAcademic, hospital or other
NCT07027020 · 60 participants (planned) · Start Jan 15, 2026 · Primary completion Jan 2028
Drug: Oxybutynin Hydrochloride; Placebo · For: Spina Bifida
Sites: Besançon, France; Bordeaux, France; Brest, France · 19 sites in all
- Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in WomenRecruiting
Mansoura UniversityAcademic, hospital or other
NCT07473310 · 70 participants (planned) · Start Nov 11, 2025 · Primary completion Jun 2027
Drug: Oral Solifenacin succinate 5 mg · For: Overactive Bladder (OAB); Urge Incontinence
Sites: Al Mansurah, Egypt
- TReating Incontinence for Underlying Mental and Physical HealthPivotal-lookingRecruiting
University of California, San FranciscoAcademic, hospital or other
NCT05362292 · 270 participants (planned) · Start Oct 4, 2022 · Primary completion May 2, 2027
Drug: Tolterodine Tartrate ER; Mirabegron and 1 more · For: Urinary Incontinence, Urge; Urinary Incontinence; Overactive Bladder and 3 more
Sites: Palo Alto, California; San Francisco, California
- Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National StudyPivotal-lookingRecruiting
Mansoura UniversityAcademic, hospital or other
NCT07416968 · 480 participants (planned) · Start Sep 1, 2025 · Primary completion Sep 2026
Drug: Tadalafil 5 mg; Solifenacin 5mg · For: Overactive Bladder (OAB); Overactive Bladder Syndrome
Sites: Shibīn al Kawm, Egypt; Zagazig, Egypt; Al Mansurah, Egypt · 14 sites in all
- Oxybutynin for Post-surgical Bladder Pain and UrgencyPivotal-lookingRecruiting
University of California, DavisAcademic, hospital or other
NCT03952299 · 100 participants (planned) · Start Sep 1, 2021 · Primary completion Dec 31, 2026
Drug: Oxybutynin Transdermal Patch; Oral Oxybutynin · For: Overactive Bladder Syndrome; Neuropathic Bladder
Sites: Sacramento, California
Alexis DieterAcademic, hospital or other
NCT07025044 · 40 participants (planned) · Start Sep 3, 2025 · Primary completion Dec 31, 2025
Drug: onabotulinum toxin type a · For: Overactive Bladder (OAB); Urge Incontinence
Sites: Washington D.C., District of Columbia
Mackay Medical CollegeAcademic, hospital or other
NCT07025642 · 60 participants (planned) · Start Jul 1, 2025 · Primary completion May 1, 2026
Drug: Urodynamic evaluation before and after solifenacin treatment.; Urodynamic evaluation before and after mirabegron treatment. and 2 more · For: Overactive Bladder (OAB)
Sites: New Taipei City, Taiwan
- Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive BladderPivotal-lookingRecruiting
Yin PingAcademic, hospital or other
NCT05798403 · 204 participants (planned) · Start Jul 7, 2023 · Primary completion Aug 31, 2025
Drug: Solifenacin Succinate Tablets · For: Overactive Bladder
Sites: Shanghai, China
Mackay Memorial HospitalAcademic, hospital or other
NCT06479720 · 300 participants (planned) · Start Jun 16, 2022 · Primary completion Jun 30, 2026
Drug: Combined pharmacotherapy with Solifenacin and Mirabegron; Solifenacin with vaginal estrogen cream and 1 more · For: Effect of Drug; Urinary Bladder, Overactive
Sites: Taipei, Taiwan
- Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor OveractivityPivotal-lookingRecruiting
Mackay Memorial HospitalAcademic, hospital or other
NCT05968885 · 300 participants (planned) · Start Oct 1, 2021 · Primary completion Jun 30, 2026
Drug: Combine Mirabegron and Solifenacin. · For: Urinary Bladder, Overactive; Urodynamics; Effect of Drug
Sites: Taipei, Taiwan
Mackay Memorial HospitalAcademic, hospital or other
NCT06197295 · 200 participants (planned) · Start Jun 16, 2022 · Primary completion Jun 30, 2026
Drug: Solifenacin with vaginal estrogen cream; Combination pharmacotherapy · For: Urinary Bladder, Overactive; Effect of Drug
Sites: Taipei, Taiwan
- Bladder Botox UTI Antibiotic ProphylaxisPivotal-lookingRecruiting
Walter Reed National Military Medical CenterFederal agency
NCT06387329 · 100 participants (planned) · Start Apr 4, 2024 · Primary completion Jun 30, 2025
Drug: Nitrofurantoin 100 MG · For: Overactive Bladder; Bladder Pain Syndrome
Sites: Bethesda, Maryland
- Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder SyndromePivotal-lookingRecruiting
Walter Reed National Military Medical CenterFederal agency
NCT05221021 · 152 participants (planned) · Start Oct 1, 2022 · Primary completion Dec 30, 2026
Drug: Vaginal estrogen; Mirabegron 50 MG [Myrbetriq] · For: Overactive Bladder Syndrome
Sites: Bethesda, Maryland
Far Eastern Memorial HospitalAcademic, hospital or other
NCT05280028 · 100 participants (planned) · Start Feb 7, 2022 · Primary completion Dec 31, 2026
Drug: Tibolone 2.5 mg; Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg · For: Menopausal Syndrome
Sites: Banqiao District, Taiwan
- Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinAPivotal-lookingRecruiting
Atlantic Health SystemAcademic, hospital or other
NCT05519072 · 140 participants (planned) · Start Aug 16, 2022 · Primary completion Aug 16, 2024
Drug: Nitrofurantoin · For: Antibiotic Prophylaxis
Sites: Morristown, New Jersey
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.